Type
. Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem. The Journal of investigative dermatology. 2004;123(6):1045-51.
Type
Status of the eradication/elimination of certain diseases from the Americas. Bulletin of the Pan American Health Organization. 1992;26(1):80-6.
Type
. Infectious neuropathies. Neurologic clinics. 2007;25(1):115-37.
Type
. Oral drug therapy for multiple neglected tropical diseases: a systematic review. JAMA. 2007;298(16):1911-24.
Type
. Present situation and new strategies for Chagas disease chemotherapy: a proposal. Memorias do Instituto Oswaldo Cruz. 2009;104(4):549-54.
Type
. [Visual evoked potentials in chronic Chagas-Mazza disease]. Arquivos de neuro-psiquiatria. 1990;48(3):315-9.
Type
. Trypsin-treated and coomassie blue-stained epimastigote antigen in a microagglutination test for Chagas' disease. The American journal of tropical medicine and hygiene. 1987;37(1):66-71.
Type
. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses. The American journal of tropical medicine and hygiene. 1986;35(1):72-8.
Type
. Immune mechanisms in inflammatory polyneuropathy. Annals of the New York Academy of Sciences. 1988;540:122-61.
Type
. Serologically active glycolipid families from Mycobacterium bovis BCG. II. Serologic studies on human sera. American journal of epidemiology. 1974;100(6):477-86.